Behavioral InterventionNO-SHOW-NCCNCT07779161
Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance
A study testing Standard phone call and phone call with MINDSPACE elements in people with Behavioral Intervention and Nicotine Addiction, run by Medical University of Gdansk at 1 site in Poland.
Trial summary
The goal of this clinical trial is to learn whether different appointment reminder methods can improve attendance at an anti-smoking (smoking cessation) clinic among adult smokers. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Behavioral Intervention, Nicotine Addiction
- What is being tested?
- Standard phone call and phone call with MINDSPACE elements
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 sitePoland
- Study dates
- Aug 2026to Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥ 18 years. Confirmed diagnosis of nicotine dependence (F17 according to the International Classification of Diseases, 10th Revision [ICD-10]) and active patient status at the Smoking Cessation Clinic.
- Provision of voluntary, written, informed consent to participate in the study and to be contacted by telephone or short text message.
- Ability to independently provide information and operate a mobile phone.
- At the time of study enrollment, attendance at an initial visit at the clinic.
Who cannot join
- Age < 18 years.
- Lack of written, informed consent to participate in the study.
- Inability to independently understand the study procedures or provide responses (e.g., due to dementia or a language barrier).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Poland1 site
University Clinical Centre
Gdansk, Pomeranian Voivodeship, 80-952
Łukasz W Balwicki, Assoc. Prof., DSc, +48 606 369 656, balwicki@gumed.edu.pl
Jagoda K Arendt
About this study
Official title: Effect of Reminder Strategies on No-Show Rates in a Nicotine Cessation Clinic: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether different appointment reminder methods can improve attendance at an anti-smoking (smoking cessation) clinic among adult smokers.
The main question it aims to answer is:
"Which reminder method helps participants come to their scheduled smoking cessation clinic appointments most often?" Researchers will compare different appointment reminder methods with standard appointment scheduling to see if they help participants attend their clinic visits more often.
Participants will:
- Receive appointment reminders using different methods
- Come to their scheduled visits at a smoking cessation (anti-nicotine) clinic
- Conditions
- Behavioral Intervention, Nicotine Addiction
- Being tested
- Standard phone call, phone call with MINDSPACE elements
- Keywords
- nicotine cessation clinic, nicotine, smoking cessation, clinic attendance, anti-nicotine clinic, adult smokers, behavioral intervention, patient engagement, reminder systems, healthcare attendance
- Medical subject headings
- Tobacco Use Disorder, Smoking Cessation, Patient Participation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard phone callBehavioural
Participants will receive a phone call from a trained staff member 1-5 days before the appointment. The conversation will follow a strictly standardized script limited solely to confirming the appointment date, without any motivational or therapeutic elements.
phone call with MINDSPACE elementsBehavioural
Also called MINDSPACE
Participants will receive a phone call 1-5 days before their appointment. The conversation will follow a standardized script incorporating behavioral intervention (nudging) elements based on the MINDSPACE framework. Key components of the script include:
- Messenger (Sender): Emphasizing that the information comes from the medical team.
- Norms (Social Norms): Referring to success statistics for regular visits.
- Commitment: Encouraging verbal confirmation of attendance.
- Affect (Emotions): Providing short messages reinforcing a sense of support.
| Study group | Role | What they receive |
|---|---|---|
| Standard of care - Text message | No intervention | Participants will receive a standard, automated text message reminding them of their scheduled appointment. The message will be sent 1 day before the scheduled appointment. The content of the message will be limited to logistical information (date, time, and location) and instructions on how to reschedule or cancel the appointment. |
| Text message and standard phone call | Experimental | Participants will receive a text message (similar to Arm 1) one day before the appointment and, additionally, a phone call from a trained staff member 1-5 days before the appointment. The conversation will follow a strictly standardized script limited solely to confirming the appointment date, without any motivational or therapeutic elements. Receives: Behavioral: Standard phone call |
| Text message and phone call with MINDSPACE elements | Experimental | Participants will receive a short text message (similar to Arm 1) and a phone call 1-5 days before their appointment. The conversation will follow a standardized script incorporating behavioral intervention (nudging) elements based on the MINDSPACE (Messenger, Incentives, Norms, Defaults, Salience, Priming, Affect, Commitments, Ego) framework. Key components of the script include:
* Messenger (Sender): Emphasizing that the information comes from the medical team.
* Norms (Social Norms): Referring to success statistics for regular visits.
* Commitment: Encouraging verbal confirmation of attendance.
* Affect (Emotions): Providing short messages reinforcing a sense of support. Receives: Behavioral: phone call with MINDSPACE elements |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient attendance at scheduled follow-up visit
Primary Outcome: The primary outcome measure is a binary assessment of patient attendance (Present/Absent) at the scheduled second visit, which takes place 2-8 weeks after the initial visit, as determined by the physician's individual assessment. Attendance will be verified on the day of the scheduled visit based on objective data recorded in the "CliniNET" hospital system.
Measured: At the second scheduled visit at the Nicotine Cessation Clinic (2-8 weeks after baseline).
Secondary outcomes (1)
Impact of sociodemographic and clinical factors on patient attendance
Secondary Outcomes: Secondary analyses will include an assessment of the impact of sociodemographic and clinical factors based on tests routinely performed as part of a medical visit (age, sex, level of dependence according to the Fagerström Test for Nicotine Dependence (FTND)).
Measured: at baseline and 2 to 8 weeks after enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Aug 2026
- Study startAug 2026 (estimated)
- Primary completionApr 2027 (estimated)
- Study completionApr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (21)Papers the sponsor has linked to this study.
- Other trials for Behavioral InterventionStudies of the same condition, open and under way.
- More trials run by Medical University of GdanskThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Medical University of Gdansk
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Łukasz Balwicki, Medical University of Gdansk
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07779161
- Sponsor's protocol ID
- KB/134/2026
- Acronym
- NO-SHOW-NCC
- Status last verified
- Aug 2026
- First submitted
- 7 Aug 2026
- Last updated
- 21 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared with other researchers. Due to privacy and confidentiality concerns, as well as applicable data protection laws, including the General Data Protection Regulation (GDPR), de-identified IPD from individual participants will not be made available.
Publications
Wu Q, Zhang R, Tao L, Cai W, Cao X, Mao Z, Zhang J. Nudge theories and strategies influencing adult health behaviors and outcomes in COPD management: a systematic review. Front Public Health. 2024 Nov 5;12:1404590. doi: 10.3389/fpubh.2024.1404590. eCollection 2024.
PubMed 39564365Wills L, Kenny PJ. Addiction-related neuroadaptations following chronic nicotine exposure. J Neurochem. 2021 Jun;157(5):1652-1673. doi: 10.1111/jnc.15356.
PubMed 33742685West R, Raw M, McNeill A, Stead L, Aveyard P, Bitton J, Stapleton J, McRobbie H, Pokhrel S, Lester-George A, Borland R. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 2015 Sep;110(9):1388-403. doi: 10.1111/add.12998.
PubMed 26031929Wang F, Li Y, Zhang C, Arbing R, Chen WT, Huang F. Evaluating digital nudge interventions for the promotion of cancer screening behavior: a systematic review and meta-analysis. BMC Med. 2025 Apr 14;23(1):214. doi: 10.1186/s12916-025-04028-8.
PubMed 40223053Tang, B. (2022). Effect of SMS reminders on attendance rates for healthcare appointments: A systematic review & meta-analysis. Journal of Clinical Case Studies Reviews&Reports, 4(5), 1-8. https://doi.org/10.47363/JCCSR/2022(4)217
Sakthisankaran, S. M., Sakthipriya, D., & Swamivelmanickam, M. (2024). Health risks associated with tobacco consumption in humans: An overview. Journal of Drug Delivery and Therapeutics, 14(5), 163-173. http://dx.doi.org/10.22270/jddt.v14i5.6523
Rohrig B, du Prel JB, Wachtlin D, Kwiecien R, Blettner M. Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2010 Aug;107(31-32):552-6. doi: 10.3238/arztebl.2010.0552. Epub 2010 Aug 9.
PubMed 20827353Pęksa, J. W., & Dembe, K. (2021). Treatment of tobacco addiction - Outline of issues. Medycyna Ogólna i Nauki o Zdrowiu, 27(1), 32-39. https://doi.org/10.26444/monz/132652
Picciotto MR, Kenny PJ. Mechanisms of Nicotine Addiction. Cold Spring Harb Perspect Med. 2021 May 3;11(5):a039610. doi: 10.1101/cshperspect.a039610.
PubMed 32341069Michalek IM, Didkowska J, Koczkodaj P. First tobacco-free generation in Europe - A lost cause? Latest Global Youth Tobacco Survey data from Poland and the CEE region. J Cancer Policy. 2025 Sep;45:100601. doi: 10.1016/j.jcpo.2025.100601. Epub 2025 May 30.
PubMed 40451610Kheirkhah P, Feng Q, Travis LM, Tavakoli-Tabasi S, Sharafkhaneh A. Prevalence, predictors and economic consequences of no-shows. BMC Health Serv Res. 2016 Jan 14;16:13. doi: 10.1186/s12913-015-1243-z.
PubMed 26769153Marcolino MS, Oliveira JAQ, D'Agostino M, Ribeiro AL, Alkmim MBM, Novillo-Ortiz D. The Impact of mHealth Interventions: Systematic Review of Systematic Reviews. JMIR Mhealth Uhealth. 2018 Jan 17;6(1):e23. doi: 10.2196/mhealth.8873.
PubMed 29343463Jankowski M, Grudziaz-Sekowska J, Kaminska A, Sekowski K, Wrzesniewska-Wal I, Moczeniat G, Gujski M, Kaleta D, Ostrowski J, Pinkas J. A 2024 nationwide cross-sectional survey to assess the prevalence of cigarette smoking, e-cigarette use and heated tobacco use in Poland. Int J Occup Med Environ Health. 2024 Sep 10;37(3):271-286. doi: 10.13075/ijomeh.1896.02402. Epub 2024 Jun 14.
PubMed 38904293Hwang AS, Atlas SJ, Cronin P, Ashburner JM, Shah SJ, He W, Hong CS. Appointment "no-shows" are an independent predictor of subsequent quality of care and resource utilization outcomes. J Gen Intern Med. 2015 Oct;30(10):1426-33. doi: 10.1007/s11606-015-3252-3. Epub 2015 Mar 17.
PubMed 25776581Hrobjartsson A, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, Tunn R, Aggarwal R, Berkwits M, Berlin JA, Bhandari N, Butcher NJ, Campbell MK, Chidebe RCW, Elbourne DR, Farmer AJ, Fergusson DA, Golub RM, Goodman SN, Hoffmann TC, Ioannidis JPA, Kahan BC, Knowles RL, Lamb SE, Lewis S, Loder E, Offringa M, Ravaud P, Richards DP, Rockhold FW, Schriger DL, Siegfried NL, Staniszewska S, Taylor RS, Thabane L, Torgerson DJ, Vohra S, White IR, Chan AW. SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials. BMJ. 2025 Apr 28;389:e081660. doi: 10.1136/bmj-2024-081660.
PubMed 40294956
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Reminder Strategies on No-Show Rates in a Nicotine Cessation Clinic: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07779161
- Acronym / sponsor ID
- NO-SHOW-NCC / KB/134/2026
- Conditions
- Behavioral Intervention, Nicotine Addiction
- Keywords
- nicotine cessation clinic, nicotine, smoking cessation, clinic attendance, anti-nicotine clinic, adult smokers, behavioral intervention, patient engagement
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Medical University of GdanskUniversity, hospital or other
- Study start
- Aug 2026 (estimated)
- Primary completion
- Apr 2027 (estimated)
- Study completion
- Apr 2027 (estimated)
- First posted
- 21 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn whether different appointment reminder methods can improve attendance at an anti-smoking (smoking cessation) clinic among adult smokers.
The main question it aims to answer is:
"Which reminder method helps participants come to their scheduled smoking cessation clinic appointments most often?" Researchers will compare different appointment reminder methods with standard appointment scheduling to see if they help participants attend their clinic visits more often.
Participants will:
- Receive appointment reminders using different methods
- Come to their scheduled visits at a smoking cessation (anti-nicotine) clinic
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Standard of care - Text message | No intervention | –Participants will receive a standard, automated text message reminding them of their scheduled appointment. The message will be sent 1 day before the scheduled appointment. The content of the message will be limited to logistical information (date, time, and location) and instructions on how to reschedule or cancel the appointment. |
| Text message and standard phone call | Experimental | Behavioral: Standard phone callParticipants will receive a text message (similar to Arm 1) one day before the appointment and, additionally, a phone call from a trained staff member 1-5 days before the appointment. The conversation will follow a strictly standardized script limited solely to confirming the appointment date, without any motivational or therapeutic elements. |
| Text message and phone call with MINDSPACE elements | Experimental | Behavioral: phone call with MINDSPACE elementsParticipants will receive a short text message (similar to Arm 1) and a phone call 1-5 days before their appointment. The conversation will follow a standardized script incorporating behavioral intervention (nudging) elements based on the MINDSPACE (Messenger, Incentives, Norms, Defaults, Salience, Priming, Affect, Commitments, Ego) framework. Key components of the script include: * Messenger (Sender): Emphasizing that the information comes from the medical team. * Norms (Social Norms): Referring to success statistics for regular visits. * Commitment: Encouraging verbal confirmation of attendance. * Affect (Emotions): Providing short messages reinforcing a sense of support. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Age ≥ 18 years. Confirmed diagnosis of nicotine dependence (F17 according to the International Classification of Diseases, 10th Revision [ICD-10]) and active patient status at the Smoking Cessation Clinic.
- Provision of voluntary, written, informed consent to participate in the study and to be contacted by telephone or short text message.
- Ability to independently provide information and operate a mobile phone.
- At the time of study enrollment, attendance at an initial visit at the clinic.
Key exclusion criteria (3 listed)
- Age < 18 years.
- Lack of written, informed consent to participate in the study.
- Inability to independently understand the study procedures or provide responses (e.g., due to dementia or a language barrier).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard phone callParticipants will receive a phone call from a trained staff member 1-5 days before the appointment. The conversation will follow a strictly standardized script limited solely to confirming the appointment date, without any motivational or therapeutic elements. | Behavioural | Text message and standard phone call |
| phone call with MINDSPACE elementsAlso: MINDSPACEParticipants will receive a phone call 1-5 days before their appointment. The conversation will follow a standardized script incorporating behavioral intervention (nudging) elements based on the MINDSPACE framework. Key components of the script include: * Messenger (Sender): Emphasizing that the information comes from the medical team. * Norms (Social Norms): Referring to success statistics for regular visits. * Commitment: Encouraging verbal confirmation of attendance. * Affect (Emotions): Providing short messages reinforcing a sense of support. | Behavioural | Text message and phone call with MINDSPACE elements |
Primary outcome
Patient attendance at scheduled follow-up visit
Time frame: At the second scheduled visit at the Nicotine Cessation Clinic (2-8 weeks after baseline).
Primary Outcome: The primary outcome measure is a binary assessment of patient attendance (Present/Absent) at the scheduled second visit, which takes place 2-8 weeks after the initial visit, as determined by the physician's individual assessment. Attendance will be verified on the day of the scheduled visit based on objective data recorded in the "CliniNET" hospital system.
1 secondary outcome
Impact of sociodemographic and clinical factors on patient attendance
Time frame: at baseline and 2 to 8 weeks after enrollment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2026.
- Background: PubMed 39564365Wu Q, Zhang R, Tao L, Cai W, Cao X, Mao Z, Zhang J. Nudge theories and strategies influencing adult health behaviors and outcomes in COPD management: a systematic review. Front Public Health. 2024 Nov 5;12:1404590. doi: 10.3389/fpubh.2024.1404590. eCollection 2024.
- Background: PubMed 33742685Wills L, Kenny PJ. Addiction-related neuroadaptations following chronic nicotine exposure. J Neurochem. 2021 Jun;157(5):1652-1673. doi: 10.1111/jnc.15356.
- Background: PubMed 26031929West R, Raw M, McNeill A, Stead L, Aveyard P, Bitton J, Stapleton J, McRobbie H, Pokhrel S, Lester-George A, Borland R. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 2015 Sep;110(9):1388-403. doi: 10.1111/add.12998.
- Background: PubMed 40223053Wang F, Li Y, Zhang C, Arbing R, Chen WT, Huang F. Evaluating digital nudge interventions for the promotion of cancer screening behavior: a systematic review and meta-analysis. BMC Med. 2025 Apr 14;23(1):214. doi: 10.1186/s12916-025-04028-8.
- BackgroundTang, B. (2022). Effect of SMS reminders on attendance rates for healthcare appointments: A systematic review & meta-analysis. Journal of Clinical Case Studies Reviews&Reports, 4(5), 1-8. https://doi.org/10.47363/JCCSR/2022(4)217
- BackgroundSakthisankaran, S. M., Sakthipriya, D., & Swamivelmanickam, M. (2024). Health risks associated with tobacco consumption in humans: An overview. Journal of Drug Delivery and Therapeutics, 14(5), 163-173. http://dx.doi.org/10.22270/jddt.v14i5.6523
- Background: PubMed 20827353Rohrig B, du Prel JB, Wachtlin D, Kwiecien R, Blettner M. Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2010 Aug;107(31-32):552-6. doi: 10.3238/arztebl.2010.0552. Epub 2010 Aug 9.
- BackgroundPęksa, J. W., & Dembe, K. (2021). Treatment of tobacco addiction - Outline of issues. Medycyna Ogólna i Nauki o Zdrowiu, 27(1), 32-39. https://doi.org/10.26444/monz/132652
- Background: PubMed 32341069Picciotto MR, Kenny PJ. Mechanisms of Nicotine Addiction. Cold Spring Harb Perspect Med. 2021 May 3;11(5):a039610. doi: 10.1101/cshperspect.a039610.
- Background: PubMed 40451610Michalek IM, Didkowska J, Koczkodaj P. First tobacco-free generation in Europe - A lost cause? Latest Global Youth Tobacco Survey data from Poland and the CEE region. J Cancer Policy. 2025 Sep;45:100601. doi: 10.1016/j.jcpo.2025.100601. Epub 2025 May 30.
- Background: PubMed 26769153Kheirkhah P, Feng Q, Travis LM, Tavakoli-Tabasi S, Sharafkhaneh A. Prevalence, predictors and economic consequences of no-shows. BMC Health Serv Res. 2016 Jan 14;16:13. doi: 10.1186/s12913-015-1243-z.
- Background: PubMed 29343463Marcolino MS, Oliveira JAQ, D'Agostino M, Ribeiro AL, Alkmim MBM, Novillo-Ortiz D. The Impact of mHealth Interventions: Systematic Review of Systematic Reviews. JMIR Mhealth Uhealth. 2018 Jan 17;6(1):e23. doi: 10.2196/mhealth.8873.
- Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, (February 2026), Poradnia Pomocy PalącymLink provided by the sponsor.
- Telefoniczna poradnia pomocy palącym (TPPP) (2026 Luty), Jak rzucić palenie Telefoniczna poradnia pomocy palącym (TPPP)Link provided by the sponsor.
- Uniwersyteckie Centrum Kliniczne w Gdańsku (2026 Luty) Uniwersyteckie Centrum Kliniczne Poradnia AntynikotynowaLink provided by the sponsor.
- WHO. (2025). Tobacco.Link provided by the sponsor.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared with other researchers. Due to privacy and confidentiality concerns, as well as applicable data protection laws, including the General Data Protection Regulation (GDPR), de-identified IPD from individual participants will not be made available.
Related trials for Behavioral Intervention
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Standard phone call and phone call with MINDSPACE elements in people with Behavioral Intervention and Nicotine Addiction, run by Medical University of Gdansk at 1 site in Poland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jagoda K Arendt (+48 509 388 251, jagoda.arendt@gumed.edu.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient attendance at scheduled follow-up visit (time frame: At the second scheduled visit at the Nicotine Cessation Clinic (2-8 weeks after baseline).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07779161, which also lists 21 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.